Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study.

Oscar Hou In ChouVinod Kumar ChauhanCheuk To Skylar ChungLei LuTeddy Tai Loy LeeZita Man Wai NgKarin Kai Wing WangSharen LeeHaipeng LiuRonald Ting Kai PangApichat KaewdechBernard Man Yung CheungGary TseJiandong Zhou

Published in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)

The use of SGLT2I was associated with lower risks of new-onset gastric cancer, PU, acute gastritis, non-acute gastritis, and GERD after matching and adjustments compared to DPP4I use. SGLT2I use was associated with lower risks of GERD and gastric cancer compared to GLP1a use.

Keyphrases

liver failure
helicobacter pylori
helicobacter pylori infection
respiratory failure
drug induced
human health
aortic dissection
risk assessment
gastroesophageal reflux disease